EBOS expands further into medical consumables

1 September 2021

NZX/ASX Code: EBO

EBOS expands further into medical consumables with the acquisition of
Sentry Medical


EBOS Group Limited (EBOS) is pleased to announce that it has completed the acquisition of Sentry
Medical.

Sentry Medical is a designer, marketer and distributor of a broad range of medical consumable
products, including its own brands and agency brands. Sentry is based in Australia and supplies to
customers including wholesalers, hospitals, general practitioners, dental surgeries, aged care
facilities, pharmacies, government agencies and vet clinics.

On 18 August 2021, along with the release of its FY21 financial results, EBOS announced that it had a
high degree of confidence of executing an acquisition within its Institutional Healthcare division
within the near term. Sentry Medical is the acquisition referred to.

Sentry Medical will further strengthen EBOS’ presence in the distribution of medical consumables to
the institutional healthcare market, which is a growing business for EBOS.

This is EBOS’ fourth acquisition completed during the last 12 months and represents a continuation
of our strategy of investing for growth.


For further information please contact:
Martin Krauskopf
General Manager, Mergers & Acquisitions and Investor Relations
+61 3 9918 5555

Authorised for lodgement with NZX and ASX by Janelle Cain, General Counsel, EBOS Group Limited.



About EBOS Group
EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified
Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical
products. It is also a leading Australasian animal care brand owner, product marketer and distributor.